Bilcare — 360° view

Bilcare, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹248 crore and net profit of ₹1.07 crore for the September 2026 quarter.

Bilcare (NSE: BI-BE) closed at ₹76.84 on 20 Nov 2026. Its market capitalisation is ₹181 crore and it trades at 5.0 times earnings.

Share price
₹76.84 (20 Nov 2026)
Market cap
₹181 Cr (20 Nov 2026)
P/E
4.97 (20 Nov 2026)
Revenue
₹248 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
7.06% (FY26)
ROE
1.39% (FY26)
Book value
₹76.0 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹113.00 / ₹70.60 (20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Research, Analytics & Technology
Symbol
NSE: BI-BE

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.